Professor of Surgery, Medical College GA
Urology
Dr. Martha K. Terris, MD
|
|
Give Review
Doctor Martha K. Terris, MD works in the field of Urology. She studied medicine at University of Mississippi School of Medicine. She has 3 awards "America's Top Doctors", "America's Top Doctors for Cancer" and "Fellow (FACS)". Martha Terris is also published. She has 96 publications published. The lastest publication: "Is computed tomography a necessary part of a metastatic evaluation for castration-resistant prostate cancer? Results from the Shared Equal Access Regional Cancer Hospi...' Martha Terris is registered with Medicare.
Publications
- Is computed tomography a necessary part of a metastatic evaluation for castration-resistant prostate cancer? Results from the Shared Equal Access Regional Cancer Hospi...
- Robert Benjamin Greenblatt and his many pursuits: an unlikely founder of the testosterone pellet.
- Factors associated with suicide in patients with genitourinary malignancies.
- Prostate-specific antigen level, stage or Gleason score: Which is best for predicting outcomes after radical prostatectomy, and does it vary by the outcome being measu...
- Is clinical stage T2c prostate cancer an intermediate- or high-risk disease?
- Postoperative statin use and risk of biochemical recurrence following radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) dat...
- Serum Lipid Profile and Risk of Prostate Cancer Recurrence: Results from the SEARCH Database.
- Re: Risk Factors for Renal Cell Carcinoma in the VITAL Study.
- Re: Matching Tumor Risk with Aggressiveness of Treatment in Men with Multiple Comorbidities and Early-stage Prostate Cancer.
- Re: volume outcomes of cystectomy-is it the surgeon or the setting?
- The impact of pathologic staging on the long-term oncologic outcomes of patients with clinically high-risk prostate cancer.
- Detectable Prostate-Specific Antigen Nadir During Androgen-Deprivation Therapy Predicts Adverse Prostate Cancer-Specific Outcomes: Results from the SEARCH Database.
- Predicting bone scan positivity after biochemical recurrence following radical prostatectomy in both hormone-naive men and patients receiving androgen-deprivation ther...
- Words of wisdom. Re: Prognostic influence of the third Gleason grade in prostatectomy specimens.
- Metformin does not affect risk of biochemical recurrence following radical prostatectomy: results from the SEARCH database.
- Emerging association between androgen deprivation therapy and male meningioma: significant expression of luteinizing hormone-releasing hormone receptor in male meningi...
- Words of wisdom. Re: Active surveillance for prostate cancer compared with immediate treatment: an economic analysis.
- Office-based ultrasound for the urologist.
- Cigarette smoking is associated with an increased risk of biochemical disease recurrence, metastasis, castration-resistant prostate cancer, and mortality after radical...
- High level of dioxin-TEQ in tissue is associated with Agent Orange exposure but not with biochemical recurrence after radical prostatectomy.
- Do nomograms designed to predict biochemical recurrence (BCR) do a better job of predicting more clinically relevant prostate cancer outcomes than BCR? A report from t...
- Re: Marital Status: A Gender-independent Risk Factor for Poorer Survival After Radical Cystectomy.
- Multi-institutional Validation of the CAPRA-S Score to Predict Disease Recurrence and Mortality After Radical Prostatectomy.
- Frederick Eugene Basil Foley: His Life and Innovations.
- Delayed radical prostatectomy for intermediate-risk prostate cancer is associated with biochemical recurrence: possible implications for active surveillance from the S...
- Re: is near infrared fluorescence imaging using indocyanine green dye useful in robotic partial nephrectomy: a prospective comparative study of 94 patients.
- Diabetes predicts metastasis after radical prostatectomy in obese men: results from the SEARCH database.
- Adult Xp11 Translocation Associated Renal Cell Carcinoma: Time to Recognize.
- The Personal Patient Profile-Prostate decision support for men localized prostate cancer: A multi-center randomized trial.
- Obesity is associated with castration-resistant disease and metastasis in men treated with androgen deprivation therapy after radical prostatectomy: results from the S...
- Metabolomic Profiling Reveals Potential Markers and Bioprocesses Altered in Bladder Cancer Progression.
- PSA velocity may not be of value in prostate cancer detection.
- Chromosomal abnormalities in renal cell carcinoma variants detected by Urovysion fluorescence in situ hybridization on paraffin-embedded tissue.
- Does PSADT after radical prostatectomy correlate with overall survival?--a report from the SEARCH database group.
- Association of cigarette smoking with interval to biochemical recurrence after radical prostatectomy: results from the SEARCH database.
- Glycemic control and prostate cancer progression: results from the SEARCH database.
- Statin medication use and the risk of biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) Database.
- Freedom from a detectable ultrasensitive prostate-specific antigen at two years after radical prostatectomy predicts a favorable clinical outcome: analysis of the SEAR...
- Diabetes and outcomes after radical prostatectomy: are results affected by obesity and race? Results from the shared equal-access regional cancer hospital database.
- Natural history of persistently elevated prostate specific antigen after radical prostatectomy: results from the SEARCH database.
- Body mass index and prostate specific antigen as predictors of adverse pathology and biochemical recurrence after prostatectomy.
- Strategies for repeat prostate biopsies.
- Race and time from diagnosis to radical prostatectomy: does equal access mean equal timely access to the operating room?--Results from the SEARCH database.
- The use of Urovysion fluorescence in situ hybridization in the diagnosis and surveillance of non-urothelial carcinoma of the bladder.
- What are the factors associated with short prostate specific antigen doubling time after radical prostatectomy? A report from the SEARCH database group.
- Editorial comment on: Agent Orange exposure, Vietnam War veterans, and the risk of prostate cancer.
- Limitations of prostate specific antigen doubling time following biochemical recurrence after radical prostatectomy: results from the SEARCH database.
- Effect of advanced age on the development of complications from intravesical bacillus Calmette-Guérin therapy.
- Is a positive bladder neck margin truly a T4 lesion in the prostate specific antigen era? Results from the SEARCH Database.
- The effect of race/ethnicity on the accuracy of the 2001 Partin Tables for predicting pathologic stage of localized prostate cancer.
- Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer.
- Race, biochemical disease recurrence, and prostate-specific antigen doubling time after radical prostatectomy: results from the SEARCH database.
- High yield of saturation prostate biopsy for patients with previous negative biopsies and small prostates.
- Body mass index, prostate weight and transrectal ultrasound prostate volume accuracy.
- Do racial differences in prostate size explain higher serum prostate-specific antigen concentrations among black men?
- Impact of obesity on the utility of preoperative prostate-specific antigen velocity to predict for relapse after prostatectomy: a report from the SEARCH database.
- Optimal timing, cutoff, and method of calculation of preoperative prostate-specific antigen velocity to predict relapse after prostatectomy: a report from SEARCH.
- Is biopsy Gleason score independently associated with biochemical progression following radical prostatectomy after adjusting for pathological Gleason score?
- Multiinstitutional validation of the UCSF cancer of the prostate risk assessment for prediction of recurrence after radical prostatectomy.
- Assessment of patient concern and adequacy of informed consent regarding infertility resulting from prostate cancer treatment.
- Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10.
- Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection.
- Association between marijuana use and transitional cell carcinoma.
- Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: a search database study.
- Interval from prostate biopsy to radical prostatectomy: effect on PSA, Gleason sum, and risk of recurrence.
- Body mass index as a predictor of prostate cancer: development versus detection on biopsy.
- Prostate biopsy volume indices do not predict for significant Gleason upgrading.
- Status of women in urology: based on a report to the Society of University Urologists.
- Primary care providers' attitudes toward prostate cancer risk factors at a Veterans Affairs health care facility.
- Biochemical outcome after radical prostatectomy among men with normal preoperative serum prostate-specific antigen levels.
- Flutamide administration at 500 mg daily has similar effects on serum testosterone to 750 mg daily.
- Lower body mass index is associated with a higher prostate cancer detection rate and less favorable pathological features in a biopsy population.
- Continuous, noninvasive, and localized microvascular tissue oximetry using visible light spectroscopy.
- Predictors of prostate-specific antigen progression among men with seminal vesicle invasion at the time of radical prostatectomy.
- Prostate cancer diagnosed in spinal cord-injured patients is more commonly advanced stage than in able-bodied patients.
- Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hosp...
- The percentage of prostate needle biopsy cores with carcinoma from the more involved side of the biopsy as a predictor of prostate specific antigen recurrence after ra...
- Luteinizing hormone-releasing hormone agonists and meningioma: a treatment dilemma.
- Comparison of preoperative prostate specific antigen density and prostate specific antigen for predicting recurrence after radical prostatectomy: results from the sear...
- Transperineal prostate biopsy after abdominoperineal resection.
- Fluorodeoxyglucose positron emission tomography studies in the diagnosis and staging of transitional cell carcinoma.
- The effect of contrast material on transitional cell carcinoma viability.
- Effectiveness of denuding the intestinal mucosa by submucosal injection in the porcine model.
- Urinary diversion in the management of chronic perineal skin ulceration in spinal cord injured patients following sphincterotomy.
- Comparison of the breaking strength of polyglactin mesh in urine, serum, and cell culture media.
- Vasectomy and prostate cancer characteristics of patients referred for prostate biopsy.
- Re: Aromatase inhibitors for male infertility.
- Facing a prostate cancer diagnosis: who is at risk for increased distress?
- Re: Transrectal ultrasound guided biopsy of the prostate. Do enemas decrease clinically significant complications?
- Application of tissue-marking ink to prostate biopsy specimens.
- Long-term culture of porcine bladder epithelial cells.
- Juxtacrine stimulation of normal and malignant human bladder epithelial cell proliferation.
- Prostate biopsy strategies: past, present, and future.
- Retrograde robotic radical prostatectomy: description of a new technique and early perioperative outcomes.
- High serum folate is associated with reduced biochemical recurrence after radical prostatectomy: Results from the SEARCH Database.
Schools
Univ Of Ms Sch Of Med
Duke U Med CtrDuke Hosp
Duke University Medical Center
Stanford Hospitals and Clinics
Mississippi State University
Procedures Preformed
- Adrenalectomy
- Bladder Surgery
- Cystometry
- Cystoscopy
- View All
Doctors Specialties
- Urologic Oncology
- Urology
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- Fellow (FACS)
Education
-
Stanford University -
Duke University Hospital -
University of Mississippi School of Medicine
Hospital
-
Georgia Regents Medical Center
Drug Facts
| NPI NUMBER | 1215948211 | |
| NPPES Provider LastName | TERRIS | |
| NPPES Provider FirstName | MARTHA | |
| NPPES Provider ZIPCode | 309120004 | |
| NPPES Provider State | GA | |
| Specialty Description | Urology | |
| Total Claim Count | 366.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1215948211 |
| Last Name Of The Provider | TERRIS |
| First Name Of The Provider | MARTHA |
| View All |
Similar Doctors
|
Dr. J D. Quarles Jr., MD |
|
|
Dr. James J. Carswell III, MD |
|
|
Dr. Henry N. Goodwin Jr., MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stanley T. Smith Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cormac E. O'Neill, MD |